Collagen supplements promise youthful skin, strong joints and glossy hair – but is a daily scoop of powder the best way to ...

Try combinations like oats with nut butter, chia seeds, and banana for a mix of slow-digesting carbs, healthy fats, and a ...

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

More than 500,000 Britons are believed to be using weight loss drugs but a waning appetite is not all they report – there’s also a lack of desire to drink alcohol ...

The demand for glucagon-like peptide 1 (GLP-1s) receptor agonists for overweight/obesity has created a clinical conundrum for ...

Chilean foodtech firm NotCo says it expects to be profitable in Chile, Argentina, Colombia, and Peru in Q2, 2025.

Migraine, a common neurological condition, poses significant personal, social, and economic burdens, requiring proper ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

Top-Line Data From MAD Part 2 of the Phase 1 Trial of DA-1726 Expected in April of 2025 Announced Positive Top-Line 16-Week Results from the Phase 2a Trial of DA-1241 ...

Most people know that using weight loss medication can throw up all sorts of side effects - some more sinister than others - ...

More recent case law has reinforced this principle, holding that when therapeutic and non-therapeutic effects are inseparably ...

Global pharmaceutical company Eli Lilly and Company (India) has introduced Mounjaro (tirzepatide) in India, a breakthrough drug for the treatment of Type 2 diabetes and obesity. Approved by the ...